GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer-Reference-Cited by-同舟云学术

GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer

Published:2014-06 Issue:6 Volume:9 Page:784-793
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Tessema Mathewos,Yingling Christin M.,Snider Amanda M.,Do Kieu,Juri Daniel E.,Picchi Maria A.,Zhang Xiequn,Liu Yushi,Leng Shuguang,Tellez Carmen S.,Belinsky Steven A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference44 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening;Dominioni;Cancer,2000

3. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

4. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy;Inoue;J Clin Oncol,2009

5. Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations;Inoue;J Clin Oncol,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma;Chinese Clinical Oncology;2024-06

2. Role of the pioneer transcription factor GATA2 in health and disease;Journal of Molecular Medicine;2023-08-25

3. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis;Current Cancer Drug Targets;2023-08

4. Identification of lysosomal genes associated with prognosis in lung adenocarcinoma;Translational Lung Cancer Research;2023-07

5. Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model;Journal of Thoracic Oncology;2023-04